# Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

> **NCT04883671** · NA · RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 32 (estimated)

## Conditions studied

- Adenoid Cystic Carcinoma
- Metastatic Adenoid Cystic Carcinoma

## Interventions

- **OTHER:** Standard of Care
- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT04883671
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-27
- **Primary completion:** 2028-06-01
- **Final completion:** 2030-06-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-09-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883671, "Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04883671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*